Urinary albumin excretion and vascular function in rheumatoid arthritis

Journal of Korean Medical Science

Volumn 31, Issue 3, 2016, Pages 382-388

  Pieringer, Herwig ^a,b   Brummaier, Tobias ^a   Piringer, Bettina ^a   Auer Hackenberg, Lorenz ^a   Hartl, Andreas ^a   Puchner, Rudolf ^c   Pohanka, Erich ^a   Schmid, Michael ^a  

^a JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c Rheumatologistin Private Practice   (Austria)

Author keywords

Albuminuria; Augmentation index; Diabetes; Rheumatoid arthritis

Indexed keywords

ALBUMINOID; CREATININE;

AGED; ALBUMINURIA; ARTERIAL STIFFNESS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PULSE WAVE; RISK FACTOR; URINE;

AGED; ALBUMINS; ALBUMINURIA; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84960468209     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2016.31.3.382     Document Type: Article

References (40)

1. Pieringer H, Pichler M. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis:vascular alterations and possible clinical implications. QJM 2011;104:13-26.
2. Pieringer H, Pichler M, Pohanka E, Hoppe UC. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis? Curr Pharm Des 2014;20:486-95.
3. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, Jardine M, Gallagher M, Turnbull F, Chalmers J, et al. The relationship between proteinuria and coronary risk:a systematic review and meta-analysis. PLoS Med 2008;5:e207.
4. Park HE, Heo NJ, Kim M, Choi SY. Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects. J Korean Med Sci 2013;28:409-14.
5. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-154.
6. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals:the Framingham Heart Study. Circulation 2005;112:969-75.
7. Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M, Fabsitz RR, Lee ET. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians:the Strong Heart Study. Am J Kidney Dis 2007;49:208-16.
8. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24-38.
9. Pieringer H, Schumacher S, Stuby U, Biesenbach G. Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls. Semin Arthritis Rheum 2009;39:163-9.
10. Pieringer H, Brummaier T, Schmid M, Pichler M, Hayat-Khayyati A, Ebner S, Biesenbach G, Pohanka E. Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors. Semin Arthritis Rheum 2012;42:17-22.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Roden M. Diabetes mellitus-definition, klassifikation und diagnose. Acta Med Austriaca 2004;31:156-7.
13. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ;National Heart, Lung, and Blood Institute, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
14. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
15. Chae HW, Shin JI, Kwon AR, Kim HS, Kim DH. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. J Korean Med Sci 2012;27:784-7.
16. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001;38:932-7.
17. Weber T, Auer J, O'rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005;26:2657-63.
18. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997;95:1827-36.
19. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts:a collaborative meta-analysis. Lancet 2010;375:2073-81.
20. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-2.
21. Lorenzo V, Saracho R, Zamora J, Rufino M, Torres A. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria. Nephrol Dial Transplant 2010;25:835-41.
22. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009;361:40-51.
23. An JH, Cho YM, Yu HG, Jang HC, Park KS, Kim SY, Lee HK. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients:a possible early stage renal complication. J Korean Med Sci 2009;24 Suppl:S75-81.
24. Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria:marker or maker of cardiovascular disease. Nephron, Exp Nephrol 2011;119 Suppl 1:e6-10.
25. Glassock RJ. Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 2010;12:364-8.
26. Seo JY, Kim MK, Choi BY, Kim YM, Cho SI, Shin J. Elevated brachial-ankle pulse wave velocity is independently associated with microalbuminuria in a rural population. J Korean Med Sci 2014;29:941-9.
27. Haraldsson B, Nyström J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008;88:451-87.
28. Comper WD, Russo LM. The glomerular filter:an imperfect barrier is required for perfect renal function. Curr Opin Nephrol Hypertens 2009;18:336-42.
29. Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells:retrieval is disrupted in nephrotic states. Kidney Int 2007;71:504-13.
30. Choi SW, Yun WJ, Kim HY, Lee YH, Kweon SS, Rhee JA, Choi JS, Shin MH. Association between albuminuria, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients. Kidney Blood Press Res 2010;33:111-8.
31. Silva AM, Schaan BD, Signori LU, Plentz RD, Moreno H Jr, Bertoluci MC, Irigoyen MC. Microalbuminuria is associated with impaired arterial and venous endothelium-dependent vasodilation in patients with Type 2 diabetes. J Endocrinol Invest 2010;33:696-700.
32. Malik AR, Sultan S, Turner ST, Kullo IJ. Urinary albumin excretion is associated with impaired flow-and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. J Hum Hypertens 2007;21:231-8.
33. de Zeeuw D. Albuminuria, just a marker for cardiovascular disease, or is it more? J Am Soc Nephrol 2005;16:1883-5.
34. Pedersen LM, Nordin H, Svensson B, Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:189-92.
35. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension:ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007;25:1751-62.
36. Daoussis D, Panoulas VF, John H, Toms TE, Antonopoulos I, Treharne G, Nightingale P, Douglas KM, Kitas GD. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era:association with hypertension, but not therapy or inflammation. Clin Rheumatol 2011;30:477-84.
37. Sellars L, Siamopoulos K, Wilkinson R, Leohapand T, Morley AR. Renal biopsy appearances in rheumatoid disease. Clin Nephrol 1983;20:114-20.
38. Boers M, Croonen AM, Dijkmans BA, Breedveld FC, Eulderink F, Cats A, Weening JJ. Renal findings in rheumatoid arthritis:clinical aspects of 132 necropsies. Ann Rheum Dis 1987;46:658-63.
39. Ramirez G, Lambert R, Bloomer HA. Renal pathology in patients with rheumatoid arthritis. Nephron 1981;28:124-6.
40. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010;8:437-49.